TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.

Trisha M Wise-Draper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.